FDA refuses to approve GSK’s respiratory drug mepolizumab for COPD

Image: GSK failed to secure FDA approval for mepolizumab for COPD guided by blood eosinophil counts. Photo: courtesy of Maxwell Hamilton. Photo: courtesy of Beyond My Ken/Wikipedia.org.